V F CORP (VFC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-28. Amounts in USD.

Revenue Quarterly

0 1.5B 3B 4.5B Q2 '17: 2.3B Q3 '17: 3.3B Q3 '17: 3B Q1 '18: 2.5B Q2 '18: 2.3B Q2 '18: 3.4B Q3 '18: 3.6B Q4 '18: 2.2B Q1 '19: 2.1B Q2 '19: 3.2B Q3 '19: 3.2B Q4 '19: 1.7B Q1 '20: 2.1B Q2 '20: 3.2B Q3 '20: 3.2B Q4 '20: 2.1B Q1 '21: 1.1B Q2 '21: 2.6B Q3 '21: 3B Q1 '22: 2.6B Q2 '22: 2.2B Q3 '22: 3.2B Q4 '22: 3.6B Q1 '23: 2.8B Q2 '23: 2.3B Q3 '23: 3.1B Q3 '23: 3.5B Q1 '24: 2.2B Q2 '24: 2.1B Q2 '24: 2.9B Q3 '24: 2.8B Q4 '24: 2.2B Q1 '25: 1.8B Q2 '25: 2.8B Q3 '25: 2.8B Q4 '25: 2.1B Q1 '26: 1.8B Q2 '26: 2.8B Q3 '26: 2.9B Q4 '26: 2.2B Q2 '18 Q2 '19 Q3 '20 Q1 '22 Q2 '23 Q2 '24 Q3 '25 Q4 '26

Gross Profit Quarterly

0 700M 1.4B 2.1B Q2 '18: 1.1B Q2 '18: 1.7B Q3 '18: 1.9B Q4 '18: 1.2B Q1 '19: 1.1B Q2 '19: 1.7B Q3 '19: 1.8B Q4 '19: 1B Q1 '20: 1.2B Q2 '20: 1.7B Q3 '20: 1.8B Q4 '20: 1.1B Q1 '21: 569.3M Q2 '21: 1.3B Q3 '21: 1.6B Q1 '22: 1.3B Q2 '22: 1.2B Q3 '22: 1.7B Q4 '22: 2B Q1 '23: 1.5B Q2 '23: 1.2B Q3 '23: 1.6B Q3 '23: 1.9B Q1 '24: 1.1B Q2 '24: 1.1B Q2 '24: 1.5B Q3 '24: 1.5B Q4 '24: 1.1B Q1 '25: 905.7M Q2 '25: 1.4B Q3 '25: 1.6B Q4 '25: 1.1B Q1 '26: 949M Q2 '26: 1.5B Q3 '26: 1.6B Q4 '26: 1.2B Q2 '18 Q2 '19 Q3 '20 Q1 '22 Q2 '23 Q2 '24 Q3 '25 Q4 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-500M -250M 0 250M 500M 750M Q1 '17: 311.8M Q2 '17: 194.4M Q3 '17: 608.2M Q3 '17: 282.4M Q1 '18: 289.7M Q2 '18: 159.7M Q2 '18: 575.5M Q3 '18: 484.6M Q4 '18: 311.4M Q1 '19: 113.1M Q2 '19: 545M Q3 '19: 520.8M Q4 '19: 126.4M Q1 '20: 96M Q2 '20: 548.6M Q3 '20: 540M Q4 '20: -256.8M Q1 '21: -246.8M Q2 '21: 319.9M Q3 '21: 412M Q1 '22: 122.5M Q2 '22: 202.9M Q3 '22: 558.5M Q4 '22: 678.4M Q1 '23: 192.4M Q2 '23: 63.4M Q3 '23: -90.8M Q3 '23: 516M Q1 '24: 510.2M Q2 '24: -9M Q2 '24: 350.5M Q3 '24: -91.2M Q1 '25: -123M Q2 '25: 273.9M Q3 '25: 225.8M Q4 '25: -72.9M Q1 '26: -86.6M Q2 '26: 312.6M Q3 '26: 289.1M Q4 '26: 61.5M Q1 '18 Q1 '19 Q2 '20 Q3 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

Net Income Quarterly

-500M -250M 0 250M 500M 750M Q3 '17: 498.5M Q3 '17: 264.3M Q1 '18: 209.2M Q2 '18: 109.9M Q2 '18: 386.1M Q3 '18: -90.3M Q4 '18: 252.8M Q1 '19: 160.4M Q2 '19: 507.1M Q3 '19: 463.5M Q4 '19: 128.8M Q1 '20: 49.2M Q2 '20: 649M Q3 '20: 465M Q4 '20: -483.8M Q1 '21: -285.6M Q2 '21: 256.7M Q3 '21: 347.2M Q1 '22: 89.5M Q2 '22: 324.2M Q3 '22: 464.1M Q4 '22: 517.8M Q1 '23: 80.8M Q2 '23: -56M Q3 '23: -118.4M Q3 '23: 507.9M Q1 '24: -214.9M Q2 '24: -57.4M Q2 '24: -450.7M Q3 '24: -42.5M Q4 '24: -418.3M Q1 '25: -258.9M Q1 '25: -258.9M Q2 '25: 52.2M Q3 '25: 167.8M Q4 '25: -150.8M Q1 '26: -116.4M Q2 '26: 189.8M Q3 '26: 300.8M Q4 '26: -119.3M Q2 '18 Q3 '19 Q4 '20 Q2 '22 Q3 '23 Q3 '24 Q3 '25 Q4 '26

Cost of Revenue Quarterly

0 700M 1.4B 2.1B Q2 '18: 1.1B Q2 '18: 1.7B Q3 '18: 1.8B Q4 '18: 1B Q1 '19: 1B Q2 '19: 1.5B Q3 '19: 1.5B Q4 '19: 640.9M Q1 '20: 896.3M Q2 '20: 1.5B Q3 '20: 1.4B Q4 '20: 986.3M Q1 '21: 507M Q2 '21: 1.3B Q3 '21: 1.3B Q1 '22: 1.2B Q2 '22: 955.6M Q3 '22: 1.5B Q4 '22: 1.6B Q1 '23: 1.4B Q2 '23: 1B Q3 '23: 1.5B Q3 '23: 1.6B Q1 '24: 1.2B Q2 '24: 985.3M Q2 '24: 1.4B Q3 '24: 1.3B Q4 '24: 1.2B Q1 '25: 863.4M Q2 '25: 1.3B Q3 '25: 1.2B Q4 '25: 1B Q1 '26: 811.7M Q2 '26: 1.3B Q3 '26: 1.2B Q4 '26: 944.1M Q2 '18 Q2 '19 Q3 '20 Q1 '22 Q2 '23 Q2 '24 Q3 '25 Q4 '26

Operating Cash Flow Quarterly

-1B -500M 0 500M 1B 1.5B Q2 '17: 162.2M Q3 '17: 30.6M Q3 '17: 1.4B Q1 '18: -210.2M Q2 '18: 205.6M Q2 '18: 11.2M Q3 '18: 1.5B Q4 '18: -243.2M Q1 '19: 277.1M Q2 '19: -174.2M Q3 '19: 1.3B Q4 '19: 227.6M Q1 '20: -66.2M Q2 '20: -299.3M Q3 '20: 1.2B Q4 '20: 32.9M Q1 '21: -3.2M Q2 '21: 86M Q3 '21: 1.1B Q1 '22: 171.2M Q2 '22: 81M Q3 '22: -252.1M Q4 '22: 968.5M Q1 '23: 66.9M Q2 '23: -358.3M Q3 '23: -555.6M Q3 '23: 80.5M Q1 '24: 177.7M Q2 '24: 163.6M Q2 '24: -182.8M Q3 '24: 1.1B Q4 '24: -91.2M Q1 '25: 19.8M Q2 '25: -301.6M Q3 '25: 918.1M Q4 '25: -171.1M Q1 '26: -145.5M Q2 '26: -227M Q3 '26: 1B Q4 '26: 33.3M Q2 '18 Q2 '19 Q3 '20 Q1 '22 Q2 '23 Q2 '24 Q3 '25 Q4 '26

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 200M 400M 600M Q1 '14: 445.9M Q2 '14: 445.6M Q4 '14: 446.3M Q1 '15: 437.1M Q2 '15: 437.6M Q1 '16: 434.1M Q2 '16: 430.7M Q3 '16: 431.5M Q1 '17: 429.1M Q2 '17: 422.1M Q3 '17: 419.2M Q1 '18: 416M Q2 '18: 400.5M Q2 '18: 397.4M Q3 '18: 400.4M Q4 '18: 401.3M Q1 '19: 399.5M Q2 '19: 401.9M Q3 '19: 399.8M Q1 '20: 401.9M Q2 '20: 402.3M Q3 '20: 400.3M Q1 '21: 390.8M Q2 '21: 391.2M Q3 '21: 392.9M Q2 '22: 394.1M Q3 '22: 394M Q4 '22: 392.5M Q2 '23: 387.6M Q3 '23: 387.7M Q3 '23: 388.2M Q2 '24: 388.2M Q2 '24: 388.3M Q3 '24: 388.4M Q1 '25: 388.7M Q2 '25: 390.9M Q3 '25: 393.9M Q1 '26: 390M Q2 '26: 394M Q3 '26: 397.2M Q2 '15 Q2 '17 Q3 '18 Q1 '20 Q3 '21 Q3 '23 Q1 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '17: 2.52 Q3 '17: 2.64 Q3 '17: 2.55 Q1 '18: 2.44 Q2 '18: 2.59 Q2 '18: 2.37 Q3 '18: 1.51 Q4 '18: 1.64 Q1 '19: 1.77 Q2 '19: 2.06 Q3 '19: 3.45 Q4 '19: 3.14 Q1 '20: 2.86 Q2 '20: 3.21 Q3 '20: 3.21 Q4 '20: 1.67 Q1 '21: 0.82 Q2 '21: -0.13 Q3 '21: -0.41 Q1 '22: 1.04 Q2 '22: 2.59 Q3 '22: 3.11 Q4 '22: 3.55 Q1 '23: 3.53 Q2 '23: 2.57 Q3 '23: 1.08 Q3 '23: 1.07 Q1 '24: 0.31 Q2 '24: 0.30 Q2 '24: -0.55 Q3 '24: -1.97 Q4 '24: -2.49 Q1 '25: -3.01 Q2 '25: -1.72 Q3 '25: -1.18 Q4 '25: -0.48 Q1 '26: -0.11 Q2 '26: 0.24 Q3 '26: 0.57 Q4 '26: 0.64 Q2 '18 Q2 '19 Q3 '20 Q1 '22 Q2 '23 Q2 '24 Q3 '25 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.